What is bioBUBBLE?
bioBUBBLE Inc. operates at the intersection of advanced engineering and life sciences, specializing in the design and deployment of softwall cleanrooms and biocontainment environments. By providing modular, flexible, and cost-effective infrastructure, the company addresses the critical needs of pharmaceutical manufacturers, academic research institutions, and biomedical laboratories. Their product portfolio, which includes sophisticated air showers and specialized enclosures, is engineered to meet rigorous safety standards while optimizing laboratory workflow efficiency. As a key provider in the life sciences supply chain, bioBUBBLE enables organizations to scale their research and production capabilities without the prohibitive costs associated with traditional, fixed-wall cleanroom construction.
How much funding has bioBUBBLE raised?
bioBUBBLE has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in bioBUBBLE
PPP
Public-Private Partnership
What's next for bioBUBBLE?
Following this major strategic investment, bioBUBBLE is poised to transition into a phase of aggressive market expansion and product innovation. The influx of capital will likely be directed toward enhancing their modular technology stack and expanding their reach into emerging pharmaceutical hubs globally. By leveraging this financial momentum, the company aims to further penetrate the R&D sector, where the demand for adaptable, high-performance containment solutions continues to rise. Future growth strategies will likely focus on deepening partnerships with large-scale pharmaceutical entities and optimizing supply chain logistics to maintain their competitive edge in the specialized laboratory infrastructure market.
See full bioBUBBLE company page
